Alpha 2.0
Login Register
» Articles » PMID: 23318536

KIR Ligand Incompatibility is Not Associated with Relapse Reduction After Double Umbilical Cord Blood Transplantation

Overview
Journal Bone Marrow Transplant
Specialty General Surgery
Date 2013 Jan 16
PMID 23318536
Citations 13
Authors
A Garfall
H T Kim
L Sun
V T Ho
P Armand
J Koreth
E P Alyea
R J Soiffer
J H Antin
J Ritz
C Cutler
Affiliations
Soon will be listed here.
Citing Articles

Role of NK cells in cord blood transplantation and their enhancement by the missing ligand effect of the killer-immunoglobulin like receptor.

Yokoyama H Front Genet. 2022; 13:1041468.

PMID: 36330445 PMC: 9623085. DOI: 10.3389/fgene.2022.1041468.

Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic Patients.

Dubreuil L, Chevallier P, Retiere C, Gagne K Cancers (Basel). 2021; 13(15).

PMID: 34359667 PMC: 8345033. DOI: 10.3390/cancers13153767.

Use of the HLA-B leader to optimize cord blood transplantation.

Petersdorf E, Gooley T, Volt F, Kenzey C, Madrigal A, McKallor C Haematologica. 2020; 106(12):3107-3114.

PMID: 33121238 PMC: 8634170. DOI: 10.3324/haematol.2020.264424.

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy.

Lupo K, Matosevic S Cancers (Basel). 2019; 11(6).

PMID: 31163679 PMC: 6628161. DOI: 10.3390/cancers11060769.

NK cell therapy for hematologic malignancies.

Mehta R, Randolph B, Daher M, Rezvani K Int J Hematol. 2018; 107(3):262-270.

PMID: 29383623 DOI: 10.1007/s12185-018-2407-5.